Cayman Chemical, 220127-57-1

1 - 1 of 1
Sort
View
Show

Benchmark BenchPress 2024 - Promos & Lab Favorites

Shakers, Incubators, Centrifuges, Balances, Rotators,
Vortexers, Dry Baths, Rockers and MORE!

Download the promotional brochure below learn more.

pdf  Benchmark BenchPress 2024 Promotional Brochure

Offers expire July 31, 2024


  • Cayman Chemical

    A first generation tyrosine kinase inhibitor that is used in the treatment of CML, GIST, and other cancers; selectively targets certain tyrosine kinases, including c-ABL, PDGFR, KIT, and the oncoprotein BCR-ABL.